India's Pharma Sector on High Alert: Trump's Tariff Plans Spark Market Volatility

Unknown Apr 02, 2026 200 Views

Nifty Pharma Index fell by 1.8% in pre-open trading after U.S. President Donald Trump reaffirmed plans to levy tariffs on drug imports. This has caused a shockwave in the Indian pharma industry that is significantly export-dependent to the U.S. Major Highlights: Trum...